Daridorexant Impurity 15 | CAS 3912-23-0 - Request Quote
Daridorexant Impurity 15
| SZ CAT No: | SZ-D142016 |
| CAS No | 3912-23-0 |
| Mol.F. | C7H6ClN3O |
| Mol.Wt. | 183.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Daridorexant Impurity 15 is chemically 1-(Chloromethoxy)-1H-benzo[d][1,2,3]triazole. Daridorexant Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Daridorexant Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Daridorexant.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 3912-23-0
Purchase 3912-23-0
Order 3912-23-0
Enquire 3912-23-0
price of 3912-23-0
3912-23-0 Supplier
3912-23-0 Manufacturer
3912-23-0 Exporter
buy high quality Daridorexant Impurity 15
Purchase Daridorexant Impurity 15
Daridorexant Impurity 15 suppliers
Daridorexant Impurity 15 manufacturers
Daridorexant Impurity 15 price
Order Daridorexant Impurity 15
Enquire Daridorexant Impurity 15
Daridorexant Impurity 15 cost
Daridorexant Impurity 15 Supplier
Daridorexant Impurity 15 Distributor
Daridorexant Impurity 15 for Method Validation
Daridorexant Reference Standard
Daridorexant Impurity 15 for ANDA Filing
Daridorexant Impurity 15 for Forced Degradation Studies
Daridorexant Impurity 15 Identification Standards
Daridorexant Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


